103 related articles for article (PubMed ID: 37244514)
1. Impact of Clinical Pharmacist Interventions on Economic Outcomes in a Cardiology Setting in Qatar.
Al-Badriyeh D; Kaddoura R; AlMaraghi F; Homosy A; Hail MA; El-Kassem W; Rouf PVA; Fadul A; Mahfouz A; Alyafei SA; Abushanab D
Curr Probl Cardiol; 2023 Sep; 48(9):101838. PubMed ID: 37244514
[TBL] [Abstract][Full Text] [Related]
2. Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar.
Abushanab D; Atchan M; Elajez R; Elshafei M; Abdelbari A; Al Hail M; Abdulrouf PV; El-Kassem W; Ademi Z; Fadul A; Abdalla E; Diab MI; Al-Badriyeh D
PLoS One; 2023; 18(6):e0286419. PubMed ID: 37262042
[TBL] [Abstract][Full Text] [Related]
3. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacists' interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis.
Yakti O; Al-Badriyeh D; Rijims M; Abdelaal M; Alsoukhni O; Al Hail M; Abdulrouf PV; El-Kassem W; Abounahia F; Kaddoura R; Abushanab D
J Pharm Policy Pract; 2024; 17(1):170-190. PubMed ID: 38236554
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.
Warden BA; Shapiro MD; Fazio S
Ann Pharmacother; 2019 Dec; 53(12):1214-1219. PubMed ID: 31342786
[No Abstract] [Full Text] [Related]
6. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
[TBL] [Abstract][Full Text] [Related]
7. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
8. Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial.
Zidan A; Awaisu A; Kheir N; Mahfoud Z; Kaddoura R; AlYafei S; El Hajj MS
BMJ Open; 2016 Nov; 6(11):e012141. PubMed ID: 27864247
[TBL] [Abstract][Full Text] [Related]
9. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore.
Chan LEJ; Soong JL; Lie SA
Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar.
Al Dali S; Al-Badriyeh D; Gulied A; Hamad A; Hail MA; Rouf PVA; El-Kassem W; Abushanab D
J Oncol Pharm Pract; 2024 Jul; 30(5):792-801. PubMed ID: 37431260
[TBL] [Abstract][Full Text] [Related]
11. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit.
Saokaew S; Maphanta S; Thangsomboon P
Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782
[TBL] [Abstract][Full Text] [Related]
12. Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital.
Zaidi ST; Hassan Y; Postma MJ; Ng SH
Pharm World Sci; 2003 Dec; 25(6):299-302. PubMed ID: 14689820
[TBL] [Abstract][Full Text] [Related]
13. Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.
Jourdan JP; Muzard A; Goyer I; Ollivier Y; Oulkhouir Y; Henri P; Parienti JJ; Breuil C
Int J Clin Pharm; 2018 Dec; 40(6):1474-1481. PubMed ID: 30367375
[TBL] [Abstract][Full Text] [Related]
14. Impact of pharmacist interventions on cost avoidance in an ambulatory cancer center.
Randolph LA; Walker CK; Nguyen AT; Zachariah SR
J Oncol Pharm Pract; 2018 Jan; 24(1):3-8. PubMed ID: 27682600
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit analysis of clinical pharmacist intervention in preventing adverse drug events in the general chronic diseases outpatients.
Al-Qudah RA; Al-Badriyeh D; Al-Ali FM; Altawalbeh SM; Basheti IA
J Eval Clin Pract; 2020 Feb; 26(1):115-124. PubMed ID: 31234234
[TBL] [Abstract][Full Text] [Related]
16. Economic Impact of Ambulatory Clinical Pharmacists in an Advanced Heart Failure Clinic.
Kido K; Colvin BM; Broscious R; Bongiorni S; Sokos G; Kamal KM
Ann Pharmacother; 2022 Feb; ():10600280221075755. PubMed ID: 35168391
[TBL] [Abstract][Full Text] [Related]
17. Clinical and economic impact of clinical pharmacist intervention in a hematology unit.
Chen PZ; Wu CC; Huang CF
J Oncol Pharm Pract; 2020 Jun; 26(4):866-872. PubMed ID: 31566112
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied.
Kheir N; Awaisu A; Gad H; Elazzazy S; Jibril F; Gajam M
Int J Clin Pharm; 2015 Dec; 37(6):1180-7. PubMed ID: 26337835
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.
Han JM; Ah YM; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Int J Clin Pharm; 2016 Oct; 38(5):1124-32. PubMed ID: 27365091
[TBL] [Abstract][Full Text] [Related]
20. Description and financial impact of ambulatory care pharmacy team interventions within an underserved patient population.
Hasham S; Moye-Dickerson P; Thurston MM
Am J Health Syst Pharm; 2023 Feb; 80(Suppl 1):S42-S48. PubMed ID: 36371741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
